Diagnostic and Therapeutic Considerations for Extramedullary Leukemia

Area of Science:

• Hematology
• Oncology
• Medical Imaging

Background:

• Extramedullary (EM) manifestations of leukemia, such as myeloid sarcoma (MS) and leukemia cutis (LC), represent a complex clinical challenge.
• These conditions require specific diagnostic and therapeutic strategies distinct from typical bone marrow involvement.

Purpose of the Study:

• To review current literature on the presentation, diagnosis, and treatment of EM leukemia, including MS and LC.
• To summarize recent advancements and ongoing challenges in managing these conditions.

Main Methods:

• Literature review of studies on EM leukemia, MS, and LC.
• Analysis of diagnostic imaging techniques, including 18FDG-PET/CT.
• Evaluation of treatment modalities such as radiation therapy, targeted agents, and immunotherapy.

Main Results:

• 18FDG-PET/CT is an effective screening tool for EM leukemia.
• Radiation therapy's role in treating MS and LC is better defined.
• While targeted agents improve AML outcomes, their specific benefit for EM manifestations is unclear; however, Ipilimumab shows potential for AML-related EM local control.

Conclusions:

• EM leukemia manifestations pose significant therapeutic challenges.
• Treatment decisions depend on bone marrow involvement, AML risk classification, and disease timing (initial diagnosis vs. relapse).
• Further research is needed to optimize targeted therapies for EM leukemia.